Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
07/2012
07/26/2012US20120189636 Human serum amyloid-a3 antibody and use thereof
07/26/2012US20120189617 Anti-tim-3 antibody
07/26/2012US20120189615 CROSS-ß STRUCTURE COMPRISING AMYLOID-BINDING PROTEINS AND METHODS FOR DETECTION OF THE CROSS-ß STRUCTURE, FOR MODULATING CROSS-ß STRUCTURES FIBER FORMATION AND FOR MODULATING CROSS-ß STRUCTURE-MEDIATED TOXICITY
07/26/2012US20120189613 Stim2-mediated capacitive calcium entry
07/26/2012US20120189606 Antimicrobial Agents
07/26/2012US20120189578 Compositions and methods for potentiating interleukin-35
07/26/2012US20120189572 Vaccines targeting cellular death receptors
07/26/2012US20120189545 Isotopically-labeled benzofuran compounds as imaging agents for amyloidogenic proteins
07/26/2012US20120189496 Spreading layer and method for producing an analysis element spreading layer
07/26/2012US20120189486 Ni-Ti SEMI-FINISHED PRODUCTS AND RELATED METHODS
07/26/2012US20120187001 Hand-held test meter with deep power conservation mode via direct or generated signal application and method for employing such a meter
07/26/2012US20120186999 Electrochemical sensor
07/26/2012US20120186997 Layered enzyme compositions for use with analyte sensors
07/26/2012US20120186996 Determination of blood glucose in a small volume and in a short test time using short read potentials
07/26/2012US20120186329 Particle sensor, exhaust system and method for determining particles in the exhaust gas
07/26/2012US20120186328 Liquid separator and apparatus for measuring a respiratory gas
07/26/2012DE102011008985A1 Method for determining additive portion, particularly ethanol portion, in fuel mixture for internal combustion engine of motor vehicle, involves determining non-stoichiometric mode of operation of internal combustion engine
07/26/2012DE102011000276A1 Vorrichtung und Verfahren zum Bestimmen der Reibung zwischen Kunststoffhohlkörpern aus gleicher Materialzusammensetzung Apparatus and method for determining the friction between plastic hollow bodies made of the same material composition
07/26/2012CA2827669A1 Methods and apparatus for detection of gluten sensitivity, and its differentiation from celiac disease
07/26/2012CA2826033A1 Methods and kits for predicting the risk of respiratory failure, renal failure or thrombopenia in a septic patient by measuring endocan levels in blood
07/26/2012CA2825709A1 Biomarkers for rapid determination of drug efficacy
07/26/2012CA2825236A1 Leukocyte activation and methods of use thereof
07/26/2012CA2825094A1 Pvrl4 (nectin 4) is a receptor for measles virus
07/26/2012CA2824910A1 Test kit and method for detection of additives in fuel compositions
07/26/2012CA2824863A1 Methods for amplification and detection of prions
07/26/2012CA2823707A1 Nav1.7 knockout mice and uses thereof
07/26/2012CA2823625A1 Medical hand-held device
07/26/2012CA2822540A1 Use of stathmin as a biomarker of drug response to furazanobenzimidazoles
07/26/2012CA2822530A1 Use of glu-tubulin as a biomarker of drug response to furazanobenzimidazoles
07/26/2012CA2822491A1 Use of bubr1 as a biomarker of drug response to furazanobenzimidazoles
07/25/2012EP2479762A1 Electric cable
07/25/2012EP2479578A1 Mass defect labeling for the determination of oligomer sequences
07/25/2012EP2479577A1 Hepatocellular carcinoma marker
07/25/2012EP2479576A1 Blood glucose meter and blood glucose level measurement method
07/25/2012EP2479575A1 Blood glucose meter
07/25/2012EP2479574A2 Predictive renal safety biomarkers and biomarker signatures to monitor kidney function
07/25/2012EP2479573A2 Predictive renal safety biomarkers and biomarker signatures to monitor kidney function
07/25/2012EP2479572A2 Predictive renal safety biomarkers and biomarker signatures to monitor kidney function
07/25/2012EP2479571A2 Predictive renal safety biomarkers and biomarker signatures to monitor kidney function
07/25/2012EP2479570A2 Predictive renal safety biomarkers and biomarker signatures to monitor kidney function
07/25/2012EP2479569A2 Predictive renal safety biomarkers and biomarker signatures to monitor kidney function
07/25/2012EP2479568A2 Predictive renal safety biomarkers and biomarker signatures to monitor kidney function
07/25/2012EP2479567A2 Predictive renal safety biomarkers and biomarker signatures to monitor kidney function
07/25/2012EP2479566A2 Predictive renal safety biomarkers and biomarker signatures to monitor kidney function
07/25/2012EP2479565A2 Predictive renal safety biomarkers and biomarker signatures to monitor kidney function
07/25/2012EP2479564A2 Predictive renal safety biomarkers and biomarker signatures to monitor kidney function
07/25/2012EP2479553A2 Particle measuring device with adjusting entrance pressure
07/25/2012EP2479551A2 A method for the toxicity assessments of nano-materials
07/25/2012EP2479290A2 Methods for the administration of iloperidone
07/25/2012EP2479287A1 Inactivatable target capture oligomers for use in the selective hybridization and capture of target nucleic acid sequences
07/25/2012EP2479286A1 MicroRNA-based methods and compositions for the diagnosis and treatment of solid cancers
07/25/2012EP2479285A1 MicroRNA-based methods and compositions for the diagnosis and treatment of solid cancers
07/25/2012EP2479284A2 Methods and reagents for treatment and diagnosis of vascular disorders and age-related macular degeneration
07/25/2012EP2479277A2 Compositions and methods of use for MGD-CSF in disease treatment
07/25/2012EP2479276A1 HLA-A*1101-restricted WT1 peptide and pharmaceutical composition comprising the same
07/25/2012EP2479275A1 HLA-A*1101-restricted WT1 peptide and pharmaceutical composition comprising the same
07/25/2012EP2479258A1 Method for isolation of dermal stem cell
07/25/2012EP2479190A1 Collagen neoepitope antibody
07/25/2012EP2478840A1 Medical hand-held device
07/25/2012EP2478838A1 Liquid separator and apparatus for measuring a respiratory gas
07/25/2012EP2478377A2 Polypeptide marker for diagnosing and assessing vascular diseases
07/25/2012EP2478376A1 A noninvasive method for measuring histamine from skin as an objective measurment of itch
07/25/2012EP2478375A1 Diagnostic agent for parkinson's disease
07/25/2012EP2478374A1 Method and kit for the classification and prognosis of wounds
07/25/2012EP2478373A1 Methods for characterizing antibody binding affinity and epitope diversity in food allergy
07/25/2012EP2478372A1 Improved method for a highly sensitive detection and quantification of biomolecules using secondary ion mass spectrometry (sims)
07/25/2012EP2478371A1 Multimarker panel for left ventricular hypertrophy
07/25/2012EP2478370A2 Dual fluorescence assay for determining viability of parasitic or non-parasitic worms
07/25/2012EP2478369A1 Apparatus and methods for analyzing fluid variables
07/25/2012EP2478368A1 Immunological assay and immunological assay kit
07/25/2012EP2478367A1 Highly sensitive immunoassay with large particle labels
07/25/2012EP2478366A1 Detection method based on time resolved real time fluorescent energy transfer (tr-fret)
07/25/2012EP2478365A1 Novel assay for the detection of amyloid beta peptides
07/25/2012EP2478364A1 Detection of antibodies
07/25/2012EP2478363A2 Identification of discriminant proteins through antibody profiling, methods and apparatus for identifying an individual
07/25/2012EP2478362A1 Use of the sparc microenvironment signature in the treatment of cancer
07/25/2012EP2478361A2 Protein kinase conjugates and inhibitors
07/25/2012EP2478360A2 Micro-rna, autoantibody and protein markers for diagnosis of neuronal injury
07/25/2012EP2478359A2 Methods of identifying anti-inflammatory compounds
07/25/2012EP2478358A1 Biomarkers for iap inhibitor compounds
07/25/2012EP2478357A1 Use of alpha-methylglucoside (amg) as an indicator for glucose absorption and excretion
07/25/2012EP2478356A1 High-throughput biomarker segmentation utilizing hierarchical normalized cuts
07/25/2012EP2478355A1 Methods for detecting autodigestion
07/25/2012EP2478345A1 Absorption biased ndir gas sensors
07/25/2012EP2478101A1 Fra-1 target genes as drug targets for treating cancer
07/25/2012EP2478008A2 Isolated australian coral reef fluorescent proteins and cell-based kinase or phosphatase platforms for cancer drug development
07/25/2012EP2478004A2 Universal fibronectin type iii binding-domain libraries
07/25/2012EP2477743A1 Disposable device for storing biological liquids and use thereof to detect materials, particles, and/or cells
07/25/2012EP2477657A1 Diagnostic and therapeutic uses of soluble fc-epsilon receptor i for ige-mediated disorders
07/25/2012EP2477640A2 Methods of treating a patient receiving a cardiac stent implant
07/25/2012EP2280723B1 Methods for species-specific immunocontraception of animals
07/25/2012EP2223121B1 Method and kit for use in the differentiation of ibd and ibs and further distinction between disease types of ibd
07/25/2012EP2185722B1 An enzyme detection device
07/25/2012EP2115021B1 Solid phase extraction of aflatoxins
07/25/2012EP2080028B1 Use of the 7f4 protein in the in vitro diagnosis of mycoplasma pneumoniae infections
07/25/2012EP1966611B1 Method for dissolution testing of pharmaceutical products
07/25/2012EP1949106B1 Method using a detection unit, in particular a biosensor
07/25/2012EP1856529B1 Compositions for use as a signal generation component and methods of using same
07/25/2012EP1751175B1 Interleukin-1 receptor antagonists, compositions, and methods of treatment
07/25/2012EP1711531B9 Neutralizing anti tlr4/md-2 antibodies and methods of use thereof
1 ... 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 ... 3937